{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T12:02:23Z","timestamp":1779364943998,"version":"3.53.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"11-12","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.cca.2011.02.026","type":"journal-article","created":{"date-parts":[[2011,2,26]],"date-time":"2011-02-26T12:06:15Z","timestamp":1298721975000},"page":"1068-1075","source":"Crossref","is-referenced-by-count":14,"title":["Impact of bezafibrate and atorvastatin on lipoprotein subclass in patients with type III hyperlipoproteinemia: Result from a crossover study"],"prefix":"10.1016","volume":"412","author":[{"given":"Masa-aki","family":"Kawashiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Nohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiaki","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Inazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2011.02.026_bb0005","author":"Rall"},{"key":"10.1016\/j.cca.2011.02.026_bb0010","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1253\/circj.69.746","article-title":"Type III hyperlipoproteinemia exaggerated by Sheehan's syndrome with advanced systemic atherosclerosis: a 28-year clinical course","volume":"69","author":"Kawashiri","year":"2005","journal-title":"Circ J"},{"key":"10.1016\/j.cca.2011.02.026_bb0015","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0022-2275(20)32417-2","article-title":"Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia). Questions, quandaries, and paradoxes","volume":"40","author":"Mahley","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2011.02.026_bb0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1055\/s-2004-861492","article-title":"Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects","volume":"4","author":"Smelt","year":"2004","journal-title":"Semin Vasc Med"},{"key":"10.1016\/j.cca.2011.02.026_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-2275(20)33334-4","article-title":"Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E","volume":"40","author":"Mahley","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2011.02.026_bb0030","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/01.RES.0000127122.22685.0A","article-title":"Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells","volume":"94","author":"Marx","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.cca.2011.02.026_bb0035","doi-asserted-by":"crossref","unstructured":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report Circulation. 2002;106:3143\u20133421.","DOI":"10.1161\/circ.106.25.3143"},{"key":"10.1016\/j.cca.2011.02.026_bb0040","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1073\/pnas.78.2.1194","article-title":"Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog","volume":"78","author":"Kovanen","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cca.2011.02.026_bb0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0026-0495(86)90106-X","article-title":"Preliminary report: treatment of type 3 hyperlipoproteinemia with mevinolin","volume":"35","author":"East","year":"1986","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2011.02.026_bb0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0021-9150(88)90107-4","article-title":"Lovastatin therapy in familial dysbetalipoproteinemia: effects on kinetics of apolipoprotein B","volume":"70","author":"Vega","year":"1988","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2011.02.026_bb0055","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0021-9150(03)00136-9","article-title":"Atorvastatin markedly improves type III hyperlipoproteinemia in association with reduction of both exogenous and endogenous apolipoprotein B-containing lipoproteins","volume":"168","author":"Ishigami","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2011.02.026_bb0060","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/heart.88.3.234","article-title":"Long-term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia","volume":"88","author":"van Dam","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.cca.2011.02.026_bb0065","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0022-2275(20)30123-1","article-title":"A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC","volume":"43","author":"Usui","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2011.02.026_bb0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cccn.2004.04.018","article-title":"Detailed analysis of serum lipids and lipoproteins from Japanese type III hyperlipoproteinemia with apolipoprotein E2\/2 phenotype","volume":"348","author":"Todo","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2011.02.026_bb0075","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/sj.clpt.6100396","article-title":"Comparison of effects of pitavastatin and atorvastatin on plasma coenzyme Q10 in heterozygous familial hypercholesterolemia: results from a crossover study","volume":"83","author":"Kawashiri","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cca.2011.02.026_bb0080","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/clinchem\/43.6.1048","article-title":"Evaluation of two homogeneous methods for measuring high-density lipoprotein cholesterol","volume":"43","author":"Huang","year":"1997","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2011.02.026_bb0085","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1093\/clinchem\/48.11.1946","article-title":"Differential reactivity of two homogeneous LDL-cholesterol methods to LDL and VLDL subfractions, as demonstrated by ultracentrifugation and HPLC","volume":"48","author":"Usui","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2011.02.026_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0009-8981(93)90062-9","article-title":"Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apoB-100 and anti apoA-I immunoaffinity mixed gel","volume":"223","author":"Nakajima","year":"1993","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2011.02.026_bb0095","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0002-8703(99)70262-0","article-title":"Comparison of the hypolipidemic effect of gemfibrozil versus simvastatin in patients with type III hyperlipoproteinemia","volume":"138","author":"Civeira","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.cca.2011.02.026_bb0100","doi-asserted-by":"crossref","first-page":"962.e1","DOI":"10.1016\/j.amjmed.2009.03.030","article-title":"Effect of fibrates on lipid profiles and cardiovascular outcomes: a systemic review","volume":"122","author":"Abourbih","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.cca.2011.02.026_bb0105","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.atherosclerosis.2006.11.035","article-title":"Effect of bezafibrate therapy on atherosclerotic aortic plaques detected by MRI in dyslipidemic patients with hypertriglyceridemia","volume":"196","author":"Ayaori","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2011.02.026_bb0110","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.metabol.2006.11.006","article-title":"Associations of apolipoprotein E polymorphism with low-density lipoprotein size and subfraction profiles in Arab patients with coronary heart disease","volume":"56","author":"Akanji","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2011.02.026_bb0115","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1194\/jlr.M500349-JLR200","article-title":"Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action","volume":"47","author":"Clark","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.cca.2011.02.026_bb0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cca.2008.12.012","article-title":"Cholesterol efflux from J774 macrophages and Fu5AH hepatoma cells to serum is preserved in CETP-deficient patients","volume":"402","author":"Miwa","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2011.02.026_bb0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0026-0495(86)90106-X","article-title":"Preliminary report: treatment of type 3 hyperlipoproteinemia with mevinolin","volume":"35","author":"East","year":"1986","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2011.02.026_bb0130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0021-9150(88)90107-4","article-title":"Lovastatin therapy in familial dysbetalipoproteinemia: effects on kinetics of apolipoprotein B","volume":"70","author":"Vega","year":"1988","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cca.2011.02.026_bb0135","first-page":"42N","article-title":"Simvastatin in the effective reduction of plasma lipoprotein levels in familial dysbetalipoproteinemia (type III hyperlipoproteinemia)","volume":"88","author":"Stuyt","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.cca.2011.02.026_bb0140","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2796.1991.tb00423.x","article-title":"Long-term effects of simvastatin in familial dysbetalipoproteinemia","volume":"230","author":"Stuyt","year":"1991","journal-title":"J Intern Med"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898111001173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898111001173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T15:05:17Z","timestamp":1637334317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898111001173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":28,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0009898111001173"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2011.02.026","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}